Side-by-side comparison of AI visibility scores, market position, and capabilities
Next-generation card issuing and embedded payment platform. San Francisco CA, raised $100M+, built by former Braintree and PayPal engineers for enterprise-grade card programs.
Highnote is a next-generation embedded card and payment platform built by fintech industry veterans from Braintree and PayPal. Founded in 2020 and headquartered in San Francisco, California, the company has raised over $100 million in funding. Highnote targets enterprises and growth-stage companies building sophisticated card programs that require more configurability and commercial terms than first-generation BaaS platforms provide.\n\nHighnote's platform covers card issuance, transaction processing, ledger management, and rewards program infrastructure through a unified API. A key differentiator is its modern ledger architecture, which provides real-time financial position tracking at the account and transaction level — enabling more accurate reconciliation and complex financial product logic than legacy processing platforms support. The platform supports both consumer and commercial card programs, credit and debit structures, and multi-currency deployments.\n\nHighnote has positioned itself as the enterprise-grade option for companies that have outgrown first-generation BaaS tools or need more sophisticated financial product configurations. Its founding team's deep experience in payment infrastructure at scale informs architectural decisions that prioritize reliability, real-time data access, and compliance flexibility. In 2024 and 2025, Highnote expanded its commercial card capabilities and launched tools for managing complex interchange optimization across large card portfolios.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.